FORUM
« Around the web, February 19 |
"Polluting Medical Judgment? False Assumptions in the Pursuit of False Claims Regarding Off-Label Prescribing" »
February 19, 2008
Anticonvulsants and suicidality, cont'd
Beck and Herrmann, blogging on the same New York Times story we did, raise a fascinating point about the possible tendency of drug trials to generate false positives as to a risk of suicidality. No matter what a drug's actual effects, they say, there may be reason to "expect more reports of suicidal behavior in the drug group than in the placebo group".
Posted by Walter Olson at 12:15 AM
| TrackBack (0)
|
categories:
Products Liability
|
|